Pan‐Chyr Yang

Active 1985–2025

Also published as
Pan-Chyr Yang
265
Papers
44,387
Citations
118
h-index
256
i10-index

Citations

Citations per year for Pan‐Chyr Yang1963: 1 citations1981: 1 citations1985: 2 citations1986: 3 citations1987: 6 citations1988: 2 citations1989: 7 citations1990: 9 citations1991: 6 citations1992: 14 citations1993: 11 citations1994: 11 citations1995: 16 citations1996: 11 citations1997: 28 citations1998: 19 citations1999: 33 citations2000: 61 citations2001: 56 citations2002: 96 citations2003: 111 citations2004: 134 citations2005: 157 citations2006: 174 citations2007: 199 citations2008: 316 citations2009: 335 citations2010: 353 citations2011: 389 citations2012: 467 citations2013: 499 citations2014: 441 citations2015: 510 citations2016: 495 citations2017: 413 citations2018: 395 citations2019: 1,357 citations2020: 1,685 citations2021: 1,392 citations2022: 967 citations2023: 673 citations2024: 1,066 citations2025: 452 citations2026: 13 citations1964–1980: no citations, so these years are not shown1982–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,799 citing papers, 21.4% of this breakdownChina: 3,542 citing papers, 19.9% of this breakdownTaiwan: 876 citing papers, 4.9% of this breakdownUnited Kingdom: 790 citing papers, 4.5% of this breakdownJapan: 759 citing papers, 4.3% of this breakdownItaly: 682 citing papers, 3.8% of this breakdownGermany: 603 citing papers, 3.4% of this breakdownSouth Korea: 528 citing papers, 3% of this breakdownFrance: 515 citing papers, 2.9% of this breakdownCanada: 496 citing papers, 2.8% of this breakdownIndia: 443 citing papers, 2.5% of this breakdownSpain: 396 citing papers, 2.2% of this breakdown
0%21.4%Other 24.4%

Fields

  • Medicine57.2%
  • Biochemistry, Genetics and Molecular Biology29.8%
  • Immunology and Microbiology4.8%
  • Materials Science1.5%
  • Engineering1.5%
  • Neuroscience1.3%
  • Other3.9%

Topics

  • Lung Cancer Treatments and Mutations6.7%
  • Lung Cancer Diagnosis and Treatment4.5%
  • Lung Cancer Research Studies2.8%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Cancer Cells and Metastasis2.1%
  • MicroRNA in disease regulation1.9%
  • Other79.8%

Coauthors

All papers

Open in search
  1. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 cited by 4,843

  2. A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

    Authors: , , , , , , , , , - Journal of Thoracic Oncology 2014 cited by 1,551

  3. Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pei‐Shan Wu, Chi-Ting Lai, Shao-Hsing Weng, Kang‐Yi Su, Wei Hung Chang, Pang-Yan Tsai, Ana I. Robles, Henry Rodriguez, Yi‐Jing Hsiao, Wen‐Hsin Chang, Ting-Yi Sung, Jin‐Shing Chen, Sung‐Liang Yu, Jyoti S. Choudhary, Hsuan‐Yu Chen, Pan‐Chyr Yang, Yu‐Ju Chen - Cell 2020 cited by 397

  4. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chun-Ku Chen, Jiun‐Yi Hsia, Chung‐Kan Peng, En‐Kuei Tang, Chia‐Lin Hsu, Teh‐Ying Chou, Wei‐Chih Shen, Ying‐Huang Tsai, Chun‐Ming Tsai, Yuh‐Min Chen, Yu‐Chin Lee, Hsuan‐Yu Chen, Sung‐Liang Yu, Chien-Jen Chen, Yung‐Liang Wan, Chao A. Hsiung, Pan‐Chyr Yang, Chang‐Chuan Chan, Si‐Wa Chan, I‐Shou Chang, Jer‐Hwa Chang, K. S. Clifford Chao, Chi‐Jen Chen, Huei‐Wen Chen, Chun‐Ju Chiang, Hung‐Yi Chiou, Mei‐Chun Chou, Chi‐Li Chung, Ta‐Jung Chung, Yue Leon Guo, Chin‐Fu Hsiao, Chien‐Sheng Huang, Sheung‐Fat Ko, Mei–Hsuan Lee, Yao‐Jen Li, Yu-San Liao, Yueh‐Hsun Lu, Hsin‐You Ou, Pingan Wu, Hwai‐I Yang, Shi‐Yi Yang, Szu‐Chun Yang - The Lancet Respiratory Medicine 2023 cited by 158

  5. Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression

    Authors: , , , , , , , , , , - Scientific Reports 2015 cited by 356

  6. ENO1 Promotes Lung Cancer Metastasis via HGFR and WNT Signaling–Driven Epithelial-to-Mesenchymal Transition

    Authors: , , , , , , , , , , , - Cancer Research 2021 cited by 192

  7. Lung Cancer Screening in Asia: An Expert Consensus Report

    Authors: , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2023 cited by 132

  8. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

    Authors: , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 1,586

  9. A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects

    Authors: , , , , - Molecular Therapy — Nucleic Acids 2016 cited by 166

  10. Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 cited by 441

  11. Precision Management of Advanced Non–Small Cell Lung Cancer

    Authors: , , - Annual Review of Medicine 2020 cited by 201

  12. Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer

    Authors: , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2023 cited by 53

  13. Stage Shift Improves Lung Cancer Survival: Real-World Evidence

    Authors: , , , , , , , , - Journal of Thoracic Oncology 2022 cited by 86

  14. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 430

  15. A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure

    Authors: , , , , - Theranostics 2019 cited by 143

  16. Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity

    Authors: , , , , , , , , , , , - Cancer Research 2019 cited by 97

  17. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: International Multidisciplinary Classification of Lung Adenocarcinoma: Executive Summary

    Authors: , , , , , , , , , , , , , , , - American Thoracic Society, Proceedings of the American Thoracic Society 2011 cited by 597

  18. TROP2 is epigenetically inactivated and modulates IGF‐1R signalling in lung adenocarcinoma

    Authors: , , , , , , , , - EMBO Molecular Medicine 2012 cited by 116

  19. PM2.5 promotes lung cancer progression through activation of the AhR‐TMPRSS2‐IL18 pathway

    Authors: , , , , , , , , , , , - EMBO Molecular Medicine 2023 cited by 79

  20. A siRNA targets and inhibits a broad range of SARS‐CoV‐2 infections including Delta variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2022 cited by 65

  21. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

    Authors: , , , , , , , , , , , , - Nature Cell Biology 2009 cited by 486

  22. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis*

    Authors: , , , - Critical Care Medicine 2005 cited by 391

  23. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 265

  24. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling

    Authors: , , , , , , , , , , , , , , - Cell Death and Disease 2015 cited by 105